MA35367B1 - Electronic cigarette - Google Patents

Electronic cigarette

Info

Publication number
MA35367B1
MA35367B1 MA35534A MA35534A MA35367B1 MA 35367 B1 MA35367 B1 MA 35367B1 MA 35534 A MA35534 A MA 35534A MA 35534 A MA35534 A MA 35534A MA 35367 B1 MA35367 B1 MA 35367B1
Authority
MA
Morocco
Prior art keywords
electronic cigarette
nicotine
relates
present
atomized
Prior art date
Application number
MA35534A
Other languages
French (fr)
Inventor
Said Bakraoui
Original Assignee
Said Bakraoui
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Said Bakraoui filed Critical Said Bakraoui
Priority to MA35534A priority Critical patent/MA35367B1/en
Publication of MA35367B1 publication Critical patent/MA35367B1/en

Links

Landscapes

  • Manufacture Of Tobacco Products (AREA)

Abstract

La présente invention concerne une cigarette électronique, en particulier ne contient pas de goudron, de nicotine (nicotine) ne contenant que la cigarette électronique atomisé.The present invention relates to an electronic cigarette, in particular does not contain tar, nicotine (nicotine) containing only the atomized electronic cigarette.

MA35534A 2013-01-04 2013-01-04 Electronic cigarette MA35367B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA35534A MA35367B1 (en) 2013-01-04 2013-01-04 Electronic cigarette

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA35534A MA35367B1 (en) 2013-01-04 2013-01-04 Electronic cigarette

Publications (1)

Publication Number Publication Date
MA35367B1 true MA35367B1 (en) 2014-09-01

Family

ID=51870759

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35534A MA35367B1 (en) 2013-01-04 2013-01-04 Electronic cigarette

Country Status (1)

Country Link
MA (1) MA35367B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222456A1 (en) * 2018-05-16 2019-11-21 Intrepid Brands, LLC Radio-frequency heating medium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222456A1 (en) * 2018-05-16 2019-11-21 Intrepid Brands, LLC Radio-frequency heating medium

Similar Documents

Publication Publication Date Title
UY34824A (en) NUCLEOSIDES OF URACILO SPYROOXETHANE
EA202092987A3 (en) LIPID CONTAINING DOCOSAPENTAENIC ACID
PH12014502350A1 (en) Mixtures, methods and compositions pertaining to conductive materials
EA201991715A1 (en) COMPOSITIONS CONTAINING AN ANTIBODY TO PDL1
TWD163815S (en) Taillights for vehicles
UY34393A (en) TETRAHYDROISOQUINOLINE COMPOUNDS REPLACED AS INHIBITORS OF THE XIA FACTOR
EA201592005A1 (en) BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
UY34817A (en) TIENOPIRIMIDINS
TWD162041S (en) Jewel
BR112016015105A2 (en) VAR2CSA-DRUG CONJUGATES
EA201600390A1 (en) COMPOSITION 1,5-DIMETHYL-6-TIOKSO-3- (2,2,7-TRIFTOR-3-OXO-4- (PROP-2-INIL) -3,4-DIGIDRO-2H-BENZO [b] [1 , 4] OXAZIN-6-IL) -1,3,5-TRIAZINAN-2,4-DIONA
WO2014043362A3 (en) Generating a point of interest profile based on third-party social comments
MA38500B1 (en) Systems and methods for analyzing animal feed
BR112018011526A2 (en) polycyclic compounds as bruton tyrosine kinase inhibitors
UY34863A (en) IAP ANTAGONISTS
CU24398B1 (en) 3- (PIPERIDIN, PIRROL OR AZETIDIN) -USUAL REPLACED INDOLES AS RORC2 INHIBITORS
UY34730A (en) PHARMACEUTICAL FORMULATIONS THAT INCLUDE CCR3 ANTAGONISTS
EA201690244A1 (en) KINAZ INHIBITORS BASED ON SIMPLE ARYL ETHERS
MX2015013363A (en) Fluorescent-hap: a diagnostic stain for hbv cores in cells.
MX2015015906A (en) Improvements in or relating to organic compounds.
UY34629A (en) Ubicuitin activating enzyme pyrazolopyrimidinyl inhibitors
MA39190A1 (en) Fused imidazolyl derivatives, their preparation and their use as medicaments
GB2523917A (en) Integration of signal sampling within transistor amplifier stage
EA201600003A1 (en) COMBINATION FOR THE TREATMENT OF CANCER CONTAINING MPS-1 INHIBITOR KINASE AND MITOSIS INHIBITOR
MA39126A3 (en) Enantiomeric synthesis of progesterone and intermediates thereof